Commentary

Thoma Bravo invests in mental health company Alma; PE-backed TAG expands to vets

Thoma Bravo announced a $130 million minority growth investment in Alma.

Novartis dashes private equity hopes with public Sandoz spin-off; Exits getting tricky for funds

LDC announced its exit from Littlefish, which is the firm's fifth exit in the last 12 months.

Blackstone to double down on tech deals in Silicon Valley; clean energy to deliver attractive returns

Blackstone expands its tech team.

EU medical device regulation boosting cross-border growth; Blackstone eyes Pink Floyd catalogue

Sun Capital Partners' Braganza: Shifts in European medical device legislation great for businesses that are well set up to do it, challenging for those who haven't seen it coming.

Centerbridge, Bridgeport agree to buy CSI; PE feels impacts as IPO windows closes

IPOs are not having a good year.

Inflation dampening healthcare dealmaking; OpenGate Capital in exclusive talks to buy Extol from MCH

The worsening economic backdrop 'clearly raises the bar for us in terms of understanding how resilient those businesses will be in the face of rising inflation', said one senior dealmaker.

Thoma Bravo puts pedal to the metal with Nearmap; Avista aims to retrace Arcadia roadmap with WellSpring

Thoma Bravo continues its tech spending spree.

Rockpool backs Finitor Wealth in double purchase; Italian government presses on with ITA Airways sale

Finitor Wealth's pickups take the firm's assets under advisement to £1.1 billion.

Investcorp, Clearlake, Atlantic Street back car parts; Amazon said to bid for Signify Health

Amazon is reportedly bidding for New Mountain-backed Signify Health.

Earth Capital flags biomass for more investment after platform launch; Apollo distances itself from Man Utd reports

'Perhaps biomass isn’t quite as glamorous as the wind farms and the solar farms, but it has to form part of a bigger strategy,' said Earth Capital's Avent Bezuidenhoudt.